免疫治疗后的细胞还原性切除术:治疗的进化,珍珠和陷
Laura E Davis1, Adam Calaway1, Eric A Singer2
1Case Western Reserve University Hospitals Urology Institute, Cleveland, OH, USA.
Journal of cellular immunology
|December 23, 2024
概括
在接受免疫治疗的精选转移性细胞癌 (mRCC) 患者中,细胞还原性切除术 (CN) 是安全且有益的. 在不断变化的mRCC治疗环境中,共享决策至关重要.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 细胞癌 (RCC) 是一种常见的癌症,有很大一部分患者被诊断为转移性疾病 (mRCC).
- 细胞还原性瘤切除术 (CN) 是mRCC中手术切除主要瘤的标准预先治疗方法,但其作用现在正在演变.
- 较小的脏瘤的发病率增加与管理先进的mRCC的持续挑战形成了鲜明对比.
研究的目的:
- 审查CN在mRCC管理中的历史和当前作用.
- 检查在接受氨酸激酶抑制剂 (TKI) 和免疫检查点抑制剂 (ICI) 治疗的患者中对CN的术后考虑.
- 了解不断发展的全身疗法对CN的指示的影响.
主要方法:
- 对mRCC的历史和当代治疗方法的文献综述.
- 在新型全身疗法背景下,分析关于CN的临床试验数据.
- 通过现代治疗来评估CN的术后安全性和疗效.
主要成果:
- CN被认为是安全的,在接受免疫治疗的精心挑选的mRCC患者中提供好处.
- 在mRCC中进行CN的决定是复杂的,因为处理环境充满动态.
- 临床试验对于完善患者选择和CN的最佳时机至关重要.
结论:
- 分享决策和多学科合作对于优化mRCC治疗至关重要.
- 临床试验的招生对于促进NC的理解和应用至关重要.
- 随着对mRCC的全身疗法的进步,CN的作用继续演变.
相关概念视频
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
01:27Cytotoxic T Cells-mediated Immune Response
844
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844